CVS HEALTH Corp (CVS) stock
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3012% above fair value
$85.81−2.78 (-3.14%)
Close on Nov 17, 2026Market cap $109.75BP/E 22.8Yield 3.10%
Cvs Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Cvs Health's revenue for the twelve months ending Jun 30, 2026 was $415.09B, up 7.4% year over year. For fiscal 2025 it was $402.07B, up 7.8% from the year before. Over ten years it grew 10.1% a year on average. The highest annual figure on record is $402.07B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $402.07B | +7.8% |
| FY2024 | Dec 31, 2024 | $372.81B | +4.2% |
| FY2023 | Dec 31, 2023 | $357.78B | +10.9% |
| FY2022 | Dec 31, 2022 | $322.47B | +10.4% |
| FY2021 | Dec 31, 2021 | $292.11B | +8.7% |
| FY2020 | Dec 31, 2020 | $268.71B | +4.6% |
| FY2019 | Dec 31, 2019 | $256.78B | +32.0% |
| FY2018 | Dec 31, 2018 | $194.58B | +5.3% |
| FY2017 | Dec 31, 2017 | $184.79B | +4.1% |
| FY2016 | Dec 31, 2016 | $177.55B | +15.8% |
| FY2015 | Dec 31, 2015 | $153.29B | +10.0% |
| FY2014 | Dec 31, 2014 | $139.37B | +9.9% |
| FY2013 | Dec 31, 2013 | $126.76B | +3.0% |
| FY2012 | Dec 31, 2012 | $123.12B | +15.0% |
| FY2011 | Dec 31, 2011 | $107.08B | +11.8% |
| FY2010 | Dec 31, 2010 | $95.78B | -2.5% |
| FY2009 | Dec 31, 2009 | $98.22B | +12.3% |
| FY2008 | Dec 31, 2008 | $87.47B | +14.6% |
| FY2007 | Dec 29, 2007 | $76.33B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $106.10B | +7.3% |
| Q1 FY2026 | Mar 31, 2026 | $100.43B | +6.2% |
| Q4 FY2025 | Dec 31, 2025 | $105.69B | +8.2% |
| Q3 FY2025 | Sep 30, 2025 | $102.87B | +7.8% |
| Q2 FY2025 | Jun 30, 2025 | $98.92B | +8.4% |
| Q1 FY2025 | Mar 31, 2025 | $94.59B | +7.0% |
| Q4 FY2024 | Dec 31, 2024 | $97.71B | +4.2% |
| Q3 FY2024 | Sep 30, 2024 | $95.43B | +6.3% |
| Q2 FY2024 | Jun 30, 2024 | $91.23B | +2.6% |
| Q1 FY2024 | Mar 31, 2024 | $88.44B | +3.7% |
| Q4 FY2023 | Dec 31, 2023 | $93.81B | +11.9% |
| Q3 FY2023 | Sep 30, 2023 | $89.76B | +10.6% |
| Q2 FY2023 | Jun 30, 2023 | $88.92B | +10.3% |
| Q1 FY2023 | Mar 31, 2023 | $85.28B | +11.0% |
| Q4 FY2022 | Dec 31, 2022 | $83.85B | +9.5% |
| Q3 FY2022 | Sep 30, 2022 | $81.16B | +10.0% |
| Q2 FY2022 | Jun 30, 2022 | $80.64B | +11.0% |
| Q1 FY2022 | Mar 31, 2022 | $76.83B | +11.2% |
| Q4 FY2021 | Dec 31, 2021 | $76.60B | +10.1% |
| Q3 FY2021 | Sep 30, 2021 | $73.79B | +10.0% |
| Q2 FY2021 | Jun 30, 2021 | $72.62B | +11.1% |
| Q1 FY2021 | Mar 31, 2021 | $69.10B | +3.5% |
| Q4 FY2020 | Dec 31, 2020 | $69.55B | +4.0% |
| Q3 FY2020 | Sep 30, 2020 | $67.06B | +3.5% |
| Q2 FY2020 | Jun 30, 2020 | $65.34B | +3.0% |
| Q1 FY2020 | Mar 31, 2020 | $66.76B | +8.3% |
| Q4 FY2019 | Dec 31, 2019 | $66.89B | +22.9% |
| Q3 FY2019 | Sep 30, 2019 | $64.81B | +36.5% |
| Q2 FY2019 | Jun 30, 2019 | $63.43B | +35.2% |
| Q1 FY2019 | Mar 31, 2019 | $61.65B | +34.8% |
| Q4 FY2018 | Dec 31, 2018 | $54.42B | +12.5% |
| Q3 FY2018 | Sep 30, 2018 | $47.49B | +2.8% |
| Q2 FY2018 | Jun 30, 2018 | $46.92B | +2.7% |
| Q1 FY2018 | Mar 31, 2018 | $45.74B | +2.7% |
| Q4 FY2017 | Dec 31, 2017 | $48.39B | +5.3% |
| Q3 FY2017 | Sep 30, 2017 | $46.19B | +3.5% |
| Q2 FY2017 | Jun 30, 2017 | $45.69B | – |
| Q1 FY2017 | Mar 31, 2017 | $44.52B | – |
| Q4 FY2016 | Dec 31, 2016 | $45.97B | – |
| Q3 FY2016 | Sep 30, 2016 | $44.62B | – |
See a number that looks wrong?